RPTX Live signals | Maximize Profits with Getagraph.com

BUY 125164 min ago

@ $7.51

Issued: 13 Feb 2024 @ 09:30

Return: -51.53%

Previous signal: Feb 12 - 09:40

Previous signal: Sell

Return: -7.28 %

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 16:00):

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States...

Stats
Today's Volume	720 631
Average Volume	207 898
Market Cap	154.50M
EPS	$0 ( 2024-02-27 )
Next earnings date	( $-0.100 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.630
ATR14	$0.0150 (0.41%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Segal Lloyd Mitchell	Sell	2 650	Common Shares
2024-04-01	Segal Lloyd Mitchell	Sell	2 491	Common Shares
2024-03-28	Forte Steve	Sell	825	Common Shares
2024-04-01	Forte Steve	Sell	789	Common Shares
2024-03-28	Zinda Michael	Sell	450	Common Shares

INSIDER POWER
71.67
Last 99 transactions
Buy: 4 214 315 \| Sell: 3 499 776

Volume Correlation

Long: -0.36 (neutral)

Short: 0.83 (strong)

Signal:(40.409) Same movement expected

Repare Therapeutics Inc. Correlation

10 Most Positive Correlations
ARKO	0.945
JRJC	0.933
HAIN	0.933
FRHC	0.932
TTEC	0.929
LUNA	0.926
SIRI	0.926
SBNYP	0.922
HCDIP	0.921
NLSP	0.92

10 Most Negative Correlations
VITL	-0.945
TRMR	-0.94
VTVT	-0.937
ROOT	-0.926
STAA	-0.923
AEYE	-0.922
PPC	-0.922
ENTX	-0.922
TWLVU	-0.913
DAKT	-0.913

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Repare Therapeutics Inc. Correlation - Currency/Commodity

0.33
( neutral )

0.64
( weak )

0.00
( neutral )

-0.27
( neutral )

-0.53
( weak negative )

0.28
( neutral )

Repare Therapeutics Inc. Financials

Annual	2023
Revenue:	$51.13M
Gross Profit:	$49.18M (96.18 %)
EPS:	$-2.23

FY	2023
Revenue:	$51.13M
Gross Profit:	$49.18M (96.18 %)
EPS:	$-2.23

FY	2022
Revenue:	$131.83M
Gross Profit:	$127.65M (96.83 %)
EPS:	$-0.690

FY	2021
Revenue:	$7.60M
Gross Profit:	$7.60M (100.00 %)
EPS:	$-2.97

Financial Reports:

No articles found.

Repare Therapeutics Inc.

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.

Realtime updates for Repare Therapeutics Inc. [RPTX]

Upcoming Earnings Alert